Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology department-Reference-Cited by-同舟云学术

Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology department

Published:2021-11-25 Issue: Volume: Page:
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Portier Elodie^ORCID,Dougados Maxime^ORCID,Moltó Anna^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00296-021-05055-3.pdf

Reference14 articles.

1. van der Heijde D, Ramiro S, Landewé R et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76:978–991. https://doi.org/10.1136/annrheumdis-2016-210770

2. Smolen JS, Braun J, Dougados M et al (2014) Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 73:6–16. https://doi.org/10.1136/annrheumdis-2013-203419

3. Dougados M (2020) Treat to target in axial spondyloarthritis: from its concept to its implementation. J Autoimmun 110:102398. https://doi.org/10.1016/j.jaut.2019.102398

4. Ramiro S, van der Heijde D, van Tubergen A et al (2014) Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 73:1455–1461. https://doi.org/10.1136/annrheumdis-2014-205178

5. Molnar C, Scherer A, Baraliakos X et al (2018) TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis 77:63–69. https://doi.org/10.1136/annrheumdis-2017-211544

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When Usual Care Is Not So Usual: Protocol Violations and Generalizability in a Treat‐to‐Target Strategy Trial in Patients With Axial Spondyloarthritis;Arthritis Care & Research;2024-07-14

2. Axial spondyloarthritis guidelines – aiming for maximum impact;Current Opinion in Rheumatology;2024-04-26

3. Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study;RMD Open;2024-02

4. Axial Spondyloarthritis Treatment Recommendations and Disease Activity Monitoring in Clinical Practice: Results of an Online Survey;The Journal of Rheumatology;2024-01-15

5. Evaluating remission and low disease activity from the perspective of the patient with axial spondyloarthritis: The cross-sectional ConREspAx study;Joint Bone Spine;2023-03